About this trial
The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.
Eligibility criteria
Qualifiers
≥ 18 yoa
patients with patients with primary or secondary liver disease not amenable for surgery or ablation
patients with primary or secondary liver tumors candidates for major surgery prior to induction of hypertrophy
able and willing to sign informed consent
Disqualifiers
pregnant women
patients with uncorrectable coagulopathy
diffuse extrahepatic disease
for lobar TACE and TARE - presence of bilodigestive shunt
Trial design
Treatments tested in this trial
- Embolization
Treatment groups
Locations
1Sponsors and collaborators
IRCCS San Raffaele
Lead sponsor